Overall, our findings support a relationship between the HDL-C/ApoA-I index with an adverse cardiometabolic profile and subclinical atherosclerosis that could be used to evaluate cardiovascular disease in adults without CAD. Here, APOA1 is linked to coronary artery disorder.